Roducitabine
Roducitabine Uses, Dosage, Side Effects, Food Interaction and all others data.
Roducitabine is under investigation in clinical trial NCT03189914 (RX-3117 in Combination With Abraxane® in Subjects With Metastatic Pancreatic Cancer).
| Trade Name | Roducitabine |
| Generic | Fluorocyclopentenylcytosine |
| Fluorocyclopentenylcytosine Other Names | Fluorocyclopentenylcytosine, Roducitabine |
| Type | |
| Formula | C10H12FN3O4 |
| Weight | Average: 257.221 Monoisotopic: 257.081184041 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here Roducitabine
